-
公开(公告)号:US20240383982A1
公开(公告)日:2024-11-21
申请号:US18289654
申请日:2022-05-09
Applicant: GENMAB A/S
Inventor: Martin SAHLIN , Abdallah ABDULRAHMAN , Jesse COE , Charles ABADIE
Abstract: The present invention relates to pharmaceutical compositions and unit dosage forms comprising antibodies binding to B7H4 and CD3. The invention further provides a use of the pharmaceutical compositions and unit dosage forms for therapeutic and diagnostic procedures, in particular in cancer therapy.